Office of Medical Communications

(MARCH 26, 2024) A representative of the University of Vermont’s Larner College of Medicine, who would be appointed by the school’s dean, will be part of an eight-member Psychedelic Therapy Advisory Working Group to study whether and how to allow therapeutic access to psychedelics, if the bill is enacted, Marijuana Moment reported.

A report from the working group would be due to the legislature in November with recommendations on how to regulate the substances.

Under the proposal in its current form, the Psychedelic Therapy Advisory Working Group would “examine the use of psychedelics to improve physical and mental health and to make findings and recommendations regarding the advisability of the establishment of a State program similar to other jurisdictions to permit health care providers to administer psychedelics in a therapeutic setting and the impact on public health of allowing individuals to legally access psychedelics under state law.”

Senators on Tuesday approved the legislation, S. 114, during second reading on a voice vote. It still needs to pass on a subsequent third reading vote in order to advance to the House of Representatives.

“This bill will start the state of Vermont on a journey to explore other possibilities and other options to treating mental illness,” Sen. Martine Larocque Gulick (D), the legislation’s sponsor, said on the Senate floor.

This topic was also covered in a Mountain Times article.